119MO Phase I/II trial evaluating the innovative therapeutic cancer vaccine PDClung01 in combination with anti-PD-1 in patients (pts) with untreated stage IV non-small cell lung cancer

Saved in:
Bibliographic Details
Published in:Immuno-oncology technology 2024-12, Vol.24
Main Authors: Vansteenkiste, J.F., Cuppens, K., Demedts, I., Borm, F., Biesma, B., Pérol, M., Theelen, W., Wauters, E., Colinet, B., Van Kerckhove, C., Buchmeier, E.L., Althoff, F.C., Pons-Tostivint, E., Derijcke, S., Moro-Sibilot, D., Sibille, A., Plumas, J., Adriaenssens, S., Cantero, F., Skrzypski, M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2590-0188
2590-0188
DOI:10.1016/j.iotech.2024.100748